Wed, Apr 23, 2014, 10:12 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

bigcoinman2002 28 posts  |  Last Activity: Apr 13, 2014 7:09 PM Member since: Aug 28, 2007
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • bigcoinman2002 bigcoinman2002 Apr 13, 2014 7:09 PM Flag

    Thanks for your response everyone.

  • Been following for a while . I see reports of scripts on this message board yielding 28-38m by year end. Assuming other business yields 10m. Let's say total is 50m for year. While certainly a very ,very nice increase of revs y/o/y ,with partner and expenses what will be the profit?
    If ...if profit is @10m that ,would put current share price at a PE of 35
    I'm not at all bearish but asking for solid reasoning as to why this is a buy.
    If I'm wrong in analysis please let me know. I know the pipeline and longer term potential but that's still a while away.

  • bigcoinman2002 by bigcoinman2002 Apr 10, 2014 8:12 AM Flag

    In a cc in 2012 we were told of a partner "by q2" . At that time we thought it so because of the FTC filing, same doc as now, in Feb 2012. If the FDA hadn't slapped this delay I'd be more convinced that finally....finally. Something would be done. Other than driving the share price higher not sure we get a partner until approval with clear indication of labeling and potential sales.

  • On February 14th you wrote.....
    Its a volatile stock. We are dealing toxic noteholders, Ironridge, and flippers. Soon the first two will end, and the flippers will be chasing to get back in. In 45 days, you'll see a much different story. If I'm wrong, I'll go away.
    Sentiment: Strong Buy

    Will you live up to your word or will continue to pump this?The share price has fallen and stil no evidence of anything they say .No outside confirmation. No SEC filings. Nothing

  • Reply to

    Love MNKD but HATE the FDA

    by bigcoinman2002 Apr 3, 2014 12:11 PM
    bigcoinman2002 bigcoinman2002 Apr 7, 2014 5:37 AM Flag

    Got to wonder what the labeling will be like IF they do approve. How horrible!!! The FDA should be investigated.

  • Reply to

    Love MNKD but HATE the FDA

    by bigcoinman2002 Apr 3, 2014 12:11 PM
    bigcoinman2002 bigcoinman2002 Apr 7, 2014 4:30 AM Flag

    Didn't think it was soft then and don't think it's soft now. FDA is corrupt. They set up the ADCOM close because they thought it would get rejected,IMO, now they're scrambling

  • bigcoinman2002 bigcoinman2002 Apr 6, 2014 2:51 PM Flag

    It was the second CRL and during ADCOM the FDA cited both efficacy and inhaler. The FDA uses the HBAc1 levels as indicative of efficacy, end though it isn't truly telling the whole story.

  • Was trying to find out if any other drugs were approved 2 weeks after ADCOM vote.
    Anyone know and can share examples either way ?
    Haven't found previous time lines on line. Thanks

  • bigcoinman2002 bigcoinman2002 Apr 4, 2014 4:19 AM Flag

    Afrezza user, another great post. Funny we've exchanged thoughts here before and I was the short guy in the black jacket at ADCOM that came up to you at the break and congratulated you on a great job...but wasn't aware it was you. Thanks as always for your great information. Really appreciate it!!

  • Reply to

    Love MNKD but HATE the FDA

    by bigcoinman2002 Apr 3, 2014 12:11 PM
    bigcoinman2002 bigcoinman2002 Apr 3, 2014 12:25 PM Flag

    I think they will approve but may delay the decision and label unfairly.

  • Reply to

    Love MNKD but HATE the FDA

    by bigcoinman2002 Apr 3, 2014 12:11 PM
    bigcoinman2002 bigcoinman2002 Apr 3, 2014 12:21 PM Flag

    This doesn't even take into account that during the FDA's presentation they stated the second CRL was because of "efficacy" and the device and of course nothing about the second CRL manipulation/criminal trading/internal approval notes.

  • bigcoinman2002 by bigcoinman2002 Apr 3, 2014 12:11 PM Flag

    I was at ADCOM and witnessed the most completely biased ,unfair, manipulative,and unreasonable FDA. During the FDA's presentation they made it clear they did not want Afrezza approved. Among the numerous unfair statements they even implied that the shorter tail of Afrezza was not like natural insulin or Exubera and therefore bad!! Fortunately one of the Drs on the panel called them out for that one later. I believe the FDA deliberately set up ADCOM close to the PDUFA date because they felt the panel would do their dirty work and not recommend approval. The FDA could come out shortly after and reject the application.
    Even the wording and arrangement of final questions was set up so that the panel would focus on the possible problems with Afrezza and not the benefits. It was deplorable.
    I don't know if the FDA has it in more Mann because of his congressional testimony or someone else is in their back pocket but the FDA certainly doesn't seem to give a s%(& about patients or the companies that spend millions to bring new innovations to the market.
    I would not be surprised to see either an FDA delay or demand an incredibly restricting label. The worst part is that Afrezza represents a new paradigm of treatment and something when used by patients , and not just in tests ,will change their lives. Eventually MNKD longs will win, just know we made be in for a bumpy road.

  • bigcoinman2002 by bigcoinman2002 Mar 28, 2014 8:47 AM Flag

    Afrezza is patient-friendly and easy to use. Previous experience with Exubera, an inhaled insulin, highlights the limitations associated with a complicated, large device.49 In contrast, the Gen2 inhaler is small and TI self-administration using this device is simple. The system relies on the patient’s inhalation effort alone to produce a flow rate that delivers TI to the pulmonary tract

  • bigcoinman2002 by bigcoinman2002 Mar 28, 2014 8:44 AM Flag

    Briefing Document MannKind Corporation AFREZZA® (Technosphere® Insulin Inhalation System) 01 Apr 2014
    From a patient’s perspective, the time-action profile of TI allows for simpler and more flexible mealtime dosing, lessens the potential for inter-prandial hypoglycemia, and enables additional prandial dosing to decrease meal-time glycemic excursion, when needed.

  • bigcoinman2002 by bigcoinman2002 Mar 27, 2014 8:27 AM Flag

    By the way,I'm flying up to attend.figure it's a once in a lifetime experience,
    I'll share some observations Wednesday for anyone that's interested. Best of luck and let's hope the FDA does the right thing this time and approves Afrezza.

  • bigcoinman2002 by bigcoinman2002 Mar 27, 2014 7:55 AM Flag

    I'm long and think that the technology,medicine,Al Mann,Deerfield.Greenhill, and the billions invested will revolutionize diabetic treatment. I bought again yesterday and will buy more today. If wrong ,like many I will lose a lot of money.
    If Afrezza is rejected or delayed all the shorts will have to take profit and buy back shares. Yes it will be at a lower price but there are so many that will need to buy shares and not many are dumb enough to try to squeeze out every penny or wait around for possible positive news or a solution to a set back.
    If Afrezza is approved all the shorts will be scrambling to buy back shares before the price moves higher.

  • bigcoinman2002 by bigcoinman2002 Mar 18, 2014 8:27 AM Flag

    Check it out!

  • Reply to

    Contact the FDA

    by eldercareattorney Mar 13, 2014 1:05 PM
    bigcoinman2002 bigcoinman2002 Mar 16, 2014 8:16 AM Flag

    I did and got response. My father suffered with this disease before passing and this would've been a great alternative. Don't think diabetics understand how this could change their lives

  • Reply to

    Hard to believe

    by joeypotsnpans Feb 21, 2014 3:58 AM
    bigcoinman2002 bigcoinman2002 Mar 14, 2014 10:15 AM Flag

    78 hours of TRADING

  • Reply to

    Partnership deal is done.

    by bigcoinman2002 Mar 4, 2014 6:31 AM
    bigcoinman2002 bigcoinman2002 Mar 4, 2014 7:36 AM Flag

    I agree with you theres some payment but it would be minimal with a milestone clause, similar to Deerfields ..get approval and x amount .
    In the meantime an announcement will cause considerable share price appreciation, particularly with so much short interest...and we know how the company feels about the short interest

30.92-0.08(-0.26%)Apr 23 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Apple Inc.
NasdaqGSWed, Apr 23, 2014 4:00 PM EDT
GW Pharmaceuticals plc
NasdaqGMWed, Apr 23, 2014 4:00 PM EDT
Facebook, Inc.
NasdaqGSWed, Apr 23, 2014 4:00 PM EDT